Aurinia Pharmaceuticals Stock Statistic Functions Beta

AUPH Stock  USD 8.98  0.03  0.34%   
Aurinia Pharmaceuticals statistic functions tool provides the execution environment for running the Beta function and other technical functions against Aurinia Pharmaceuticals. Aurinia Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Aurinia Pharmaceuticals statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Aurinia Pharmaceuticals correlated with the market. If Beta is less than 0 Aurinia Pharmaceuticals generally moves in the opposite direction as compared to the market. If Aurinia Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aurinia Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aurinia Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Aurinia Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.

Aurinia Pharmaceuticals Technical Analysis Modules

Most technical analysis of Aurinia Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aurinia from various momentum indicators to cycle indicators. When you analyze Aurinia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aurinia Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aurinia Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aurinia Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aurinia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aurinia Pharmaceuticals's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Aurinia Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Aurinia Pharmaceuticals, we also check how macroeconomic factors affect Aurinia Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover0.281.833.272.2
Days Of Inventory On Hand6.5K1.6K1.0K1.1K
Hype
Prediction
LowEstimatedHigh
5.979.0412.11
Details
Intrinsic
Valuation
LowRealHigh
7.7210.7913.86
Details
7 Analysts
Consensus
LowTargetHigh
12.7414.0015.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.010.010.06
Details

Align your values with your investing style

In addition to having Aurinia Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested over 40 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Impulse Idea
Impulse
Invested few shares
Investing Idea
Investing
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
FinTech Idea
FinTech
Invested few shares
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
1.536
Quarterly Revenue Growth
0.243
Return On Assets
(0.02)
Return On Equity
(0.06)
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.